- Home
- PLAB vs XNCR Comparison
PLAB vs XNCR Comparison
Compare PLAB & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAB
- XNCR
- Stock Information
- Founded
- PLAB 1969
- XNCR 1997
- Country
- PLAB United States
- XNCR United States
- Employees
- PLAB N/A
- XNCR N/A
- Industry
- PLAB Semiconductors
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- PLAB Technology
- XNCR Health Care
- Exchange
- PLAB Nasdaq
- XNCR Nasdaq
- Market Cap
- PLAB 1.6B
- XNCR 1.5B
- IPO Year
- PLAB 1987
- XNCR 2013
- Fundamental
- Price
- PLAB $24.44
- XNCR $24.10
- Analyst Decision
- PLAB
- XNCR Strong Buy
- Analyst Count
- PLAB 0
- XNCR 8
- Target Price
- PLAB N/A
- XNCR $35.50
- AVG Volume (30 Days)
- PLAB 331.3K
- XNCR 569.4K
- Earning Date
- PLAB 12-11-2024
- XNCR 11-06-2024
- Dividend Yield
- PLAB N/A
- XNCR N/A
- EPS Growth
- PLAB 18.80
- XNCR N/A
- EPS
- PLAB 2.27
- XNCR N/A
- Revenue
- PLAB $871,791,000.00
- XNCR $85,164,000.00
- Revenue This Year
- PLAB N/A
- XNCR N/A
- Revenue Next Year
- PLAB $9.01
- XNCR $86.53
- P/E Ratio
- PLAB $10.77
- XNCR N/A
- Revenue Growth
- PLAB N/A
- XNCR N/A
- 52 Week Low
- PLAB $20.25
- XNCR $15.31
- 52 Week High
- PLAB $34.16
- XNCR $26.84
- Technical
- Relative Strength Index (RSI)
- PLAB 52.13
- XNCR 70.71
- Support Level
- PLAB $23.42
- XNCR $22.60
- Resistance Level
- PLAB $26.30
- XNCR $23.86
- Average True Range (ATR)
- PLAB 0.72
- XNCR 0.83
- MACD
- PLAB -0.07
- XNCR 0.05
- Stochastic Oscillator
- PLAB 45.61
- XNCR 96.85
About PLAB Photronics Inc.
Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue worldwide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.